Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > NEMAURA PHARMA LIMITED
Company Information for

NEMAURA PHARMA LIMITED

ADVANCED TECHNOLOGY INNOVATION CENTRE, LOUGHBOROUGH UNIVERSITY SCIENCE AND ENTERPRISE, PARKS, 5 OAKWOOD DRIVE, LOUGHBOROUGH, LEICESTERSHIRE, LE11 3QF,
Company Registration Number
05636878
Private Limited Company
Active

Company Overview

About Nemaura Pharma Ltd
NEMAURA PHARMA LIMITED was founded on 2005-11-25 and has its registered office in Loughborough. The organisation's status is listed as "Active". Nemaura Pharma Limited is a Private Limited Company registered in with Companies House and the accounts submission requirement is categorised as TOTAL EXEMPTION FULL
  • Company qualifies as a small company
  • Company has filed full accounts
  • Company is exempt from audit
  • Annual turnover is less than £6.5 million
  • The balance sheet total is less than £ 3.26 million
  • Employs less than 50 employees
Key Data
Company Name
NEMAURA PHARMA LIMITED
 
Legal Registered Office
ADVANCED TECHNOLOGY INNOVATION CENTRE, LOUGHBOROUGH UNIVERSITY SCIENCE AND ENTERPRISE
PARKS, 5 OAKWOOD DRIVE
LOUGHBOROUGH
LEICESTERSHIRE
LE11 3QF
Other companies in LE11
 
Filing Information
Company Number 05636878
Company ID Number 05636878
Date formed 2005-11-25
Country 
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 31/03/2023
Account next due 31/12/2024
Latest return 25/11/2015
Return next due 23/12/2016
Type of accounts TOTAL EXEMPTION FULL
VAT Number /Sales tax ID GB834614137  
Last Datalog update: 2024-01-07 16:59:10
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for NEMAURA PHARMA LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of NEMAURA PHARMA LIMITED

Current Directors
Officer Role Date Appointed
BASHIR TIMOL
Company Secretary 2007-10-26
DEWAN FAZLUL HOQUE CHOWDHURY
Director 2005-11-25
BASHIR TIMOL
Director 2007-10-26
Previous Officers
Officer Role Date Appointed Date Resigned
DEWAN FAZLUL HOQUE CHOWDHURY
Company Secretary 2005-11-25 2007-10-26

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
BASHIR TIMOL SABT1 LIMITED Company Secretary 2009-03-25 CURRENT 2009-03-25 Active
BASHIR TIMOL ONEE GROUP LIMITED Company Secretary 2007-01-30 CURRENT 2007-01-30 Active
BASHIR TIMOL ONEE TAX LIMITED Company Secretary 2006-06-01 CURRENT 2006-06-01 Liquidation
BASHIR TIMOL 1ST ETHICAL TAX PLANNING LTD Company Secretary 2004-06-17 CURRENT 2004-06-17 Dissolved 2014-05-04
DEWAN FAZLUL HOQUE CHOWDHURY NPL FC LIMITED Director 2014-12-05 CURRENT 2014-12-05 Active
DEWAN FAZLUL HOQUE CHOWDHURY BRITTLE BONE MEDICINE LIMITED Director 2014-09-16 CURRENT 2014-09-16 Active
DEWAN FAZLUL HOQUE CHOWDHURY DERMAL DIAGNOSTICS (HOLDINGS) LIMITED Director 2013-12-11 CURRENT 2013-12-11 Active
DEWAN FAZLUL HOQUE CHOWDHURY BLACK AND WHITE HEALTH CARE LIMITED Director 2012-10-05 CURRENT 2012-10-05 Active
DEWAN FAZLUL HOQUE CHOWDHURY TRIAL CLINIC LIMITED Director 2011-08-23 CURRENT 2011-01-12 Active
DEWAN FAZLUL HOQUE CHOWDHURY PINNACLE IMP LIMITED Director 2010-02-19 CURRENT 2010-02-19 Active
DEWAN FAZLUL HOQUE CHOWDHURY NDM TECHNOLOGIES LIMITED Director 2010-02-19 CURRENT 2010-02-19 Active
DEWAN FAZLUL HOQUE CHOWDHURY MICRONEEDLE TECHNOLOGIES LIMITED Director 2009-10-22 CURRENT 2009-10-22 Active
DEWAN FAZLUL HOQUE CHOWDHURY DERMAL DIAGNOSTICS LIMITED Director 2009-01-20 CURRENT 2009-01-20 Active
DEWAN FAZLUL HOQUE CHOWDHURY MEDILINK EAST MIDLANDS LIMITED Director 2008-05-30 CURRENT 2004-01-26 Active
BASHIR TIMOL NO 19 WINCKLEY SQUARE (PRESTON) MANAGEMENT COMPANY LIMITED Director 2016-01-26 CURRENT 2016-01-26 Active
BASHIR TIMOL NPL FC LIMITED Director 2014-12-05 CURRENT 2014-12-05 Active
BASHIR TIMOL DERMAL DIAGNOSTICS (HOLDINGS) LIMITED Director 2013-12-11 CURRENT 2013-12-11 Active
BASHIR TIMOL ONEE DESIGNATED ADMINISTRATOR LIMITED Director 2013-10-03 CURRENT 2013-10-03 Active - Proposal to Strike off
BASHIR TIMOL TRIAL CLINIC LIMITED Director 2011-08-18 CURRENT 2011-01-12 Active
BASHIR TIMOL SABT1 LIMITED Director 2009-03-25 CURRENT 2009-03-25 Active
BASHIR TIMOL ONEE GROUP LIMITED Director 2007-01-31 CURRENT 2007-01-30 Active
BASHIR TIMOL ONEE TAX LIMITED Director 2006-06-01 CURRENT 2006-06-01 Liquidation
BASHIR TIMOL 1ST ETHICAL TAX PLANNING LTD Director 2005-06-18 CURRENT 2004-06-17 Dissolved 2014-05-04

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2024-05-02STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 1
2022-12-2131/03/22 ACCOUNTS TOTAL EXEMPTION FULL
2022-12-21AA31/03/22 ACCOUNTS TOTAL EXEMPTION FULL
2022-11-01CS01CONFIRMATION STATEMENT MADE ON 15/10/22, WITH NO UPDATES
2021-12-1631/03/21 ACCOUNTS TOTAL EXEMPTION FULL
2021-12-1631/03/21 ACCOUNTS TOTAL EXEMPTION FULL
2021-12-16AA31/03/21 ACCOUNTS TOTAL EXEMPTION FULL
2021-10-27CS01CONFIRMATION STATEMENT MADE ON 15/10/21, WITH NO UPDATES
2021-03-24AA31/03/20 ACCOUNTS TOTAL EXEMPTION FULL
2020-10-21CS01CONFIRMATION STATEMENT MADE ON 15/10/20, WITH NO UPDATES
2020-04-28AASMALL COMPANY ACCOUNTS MADE UP TO 31/03/19
2019-12-03CS01CONFIRMATION STATEMENT MADE ON 15/10/19, WITH UPDATES
2019-01-09CS01CONFIRMATION STATEMENT MADE ON 25/11/18, WITH UPDATES
2018-12-30AA31/03/18 ACCOUNTS TOTAL EXEMPTION FULL
2018-03-29LATEST SOC04/04/18 STATEMENT OF CAPITAL;GBP 18417.62
2018-03-29SH19Statement of capital on 2018-03-29 GBP 18,417.62
2018-03-29ANNOTATIONClarification
2018-01-16LATEST SOC16/01/18 STATEMENT OF CAPITAL;GBP 12000
2018-01-16CS01CONFIRMATION STATEMENT MADE ON 25/11/17, WITH UPDATES
2018-01-04AASMALL COMPANY ACCOUNTS MADE UP TO 31/03/17
2017-09-19LATEST SOC19/09/17 STATEMENT OF CAPITAL;GBP 9000
2017-09-19SH1919/09/17 STATEMENT OF CAPITAL GBP 9000
2017-09-19SH1919/09/17 STATEMENT OF CAPITAL GBP 9000
2017-08-24SH20Statement by Directors
2017-08-24CAP-SSSolvency Statement dated 28/06/17
2017-08-24RES13Resolutions passed:
  • Reduce share prem a/c 28/06/2017
2017-01-31LATEST SOC31/01/17 STATEMENT OF CAPITAL;GBP 12000
2017-01-31CS01CONFIRMATION STATEMENT MADE ON 25/11/16, WITH UPDATES
2017-01-09AASMALL COMPANY ACCOUNTS MADE UP TO 31/03/16
2016-02-16ANNOTATIONClarification
2016-02-16RP04
2016-01-15LATEST SOC15/01/16 STATEMENT OF CAPITAL;GBP 12000
2016-01-15AR0125/11/15 ANNUAL RETURN FULL LIST
2016-01-07ANNOTATIONClarification
2016-01-07RP04
2016-01-07AASMALL COMPANY ACCOUNTS MADE UP TO 31/03/15
2015-09-14AD01REGISTERED OFFICE CHANGED ON 14/09/15 FROM C/O Loughborough Innovation Centre Charnwood Building Ashby Road Loughborough Leicestershire LE11 3AQ
2015-01-09AASMALL COMPANY ACCOUNTS MADE UP TO 31/03/14
2015-01-05LATEST SOC05/01/15 STATEMENT OF CAPITAL;GBP 210000
2015-01-05AR0125/11/14 ANNUAL RETURN FULL LIST
2014-06-23RES13COMPANY BUSINESS 13/06/2014
2014-06-23RES10Resolutions passed:
  • Resolution of allotment of securities
  • Company business 13/06/2014
  • Resolution of removal of pre-emption rights
2014-06-23SH0113/06/14 STATEMENT OF CAPITAL GBP 210000
2014-06-23SH0113/06/14 STATEMENT OF CAPITAL GBP 210000
2014-03-11AR0125/11/08 NO CHANGES AMEND
2014-03-11AR0125/11/07 FULL LIST AMEND
2014-03-07RP04SECOND FILING WITH MUD 25/11/13 FOR FORM AR01
2014-03-07RP04SECOND FILING WITH MUD 25/11/12 FOR FORM AR01
2014-03-07RP04SECOND FILING WITH MUD 25/11/11 FOR FORM AR01
2014-03-07RP04SECOND FILING WITH MUD 25/11/10 FOR FORM AR01
2014-03-07RP04SECOND FILING WITH MUD 25/11/09 FOR FORM AR01
2014-03-07ANNOTATIONClarification
2013-12-23AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/03/13
2013-12-20AR0125/11/13 FULL LIST
2012-12-28AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/03/12
2012-12-17AR0125/11/12 FULL LIST
2011-12-27AA31/03/11 TOTAL EXEMPTION SMALL
2011-12-14AR0125/11/11 FULL LIST
2011-10-13MG01PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 1
2011-02-28AD01REGISTERED OFFICE CHANGED ON 28/02/2011 FROM, UNIT 16 ,, LOUGHBOROUGH INNOVATION CENTRE, EPINAL WAY, LOUGHBOROUGH, LE11 3EH
2011-01-05AR0125/11/10 FULL LIST
2010-12-16AA31/03/10 TOTAL EXEMPTION SMALL
2010-01-31AA31/03/09 TOTAL EXEMPTION SMALL
2010-01-22AR0125/11/09 FULL LIST
2010-01-22CH01DIRECTOR'S CHANGE OF PARTICULARS / MR BASHIR TIMOL / 25/11/2009
2009-01-3088(2)AMENDING 88(2)
2009-01-26AA31/03/08 TOTAL EXEMPTION SMALL
2009-01-22363aRETURN MADE UP TO 25/11/08; FULL LIST OF MEMBERS
2008-06-02363aRETURN MADE UP TO 25/11/07; FULL LIST OF MEMBERS
2008-06-02288bAPPOINTMENT TERMINATED SECRETARY DEWAN CHOWDHURY
2008-03-26RES04GBP NC 1000/10000 26/10/2007
2008-03-26123NC INC ALREADY ADJUSTED 26/10/07
2008-03-26RES01ADOPT ARTICLES 26/10/2007
2008-03-26RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2008-03-26RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2008-03-2688(2)AD 26/10/07 GBP SI 9000@1=9000 GBP IC 1000/10000
2008-03-10288aDIRECTOR AND SECRETARY APPOINTED BASHIR TIMOL
2007-09-24AATOTAL EXEMPTION SMALL ACCOUNTS MADE UP TO 31/03/07
2007-08-10225ACC. REF. DATE EXTENDED FROM 30/11/06 TO 31/03/07
2007-02-13363aRETURN MADE UP TO 25/11/06; FULL LIST OF MEMBERS
2005-11-25NEWINCINCORPORATION DOCUMENTS CERTIFICATE OF INCORPORATION STATEMENT OF DIRECTORS & REGISTERED OFFICE DECLARATION OF COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72190 - Other research and experimental development on natural sciences and engineering




Licences & Regulatory approval
We could not find any licences issued to NEMAURA PHARMA LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
Petitions to Wind Up (Companies)2024-03-11
Fines / Sanctions
No fines or sanctions have been issued against NEMAURA PHARMA LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 1
Mortgages/Charges outstanding 1
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
Charge Type Date of Charge Charge Status Mortgagee
DEBENTURE 2011-10-13 Outstanding TRIAL CLINIC LIMITED
Filed Financial Reports
Annual Accounts
2021-03-31

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on NEMAURA PHARMA LIMITED

Intangible Assets
Patents

Intellectual Property Patents Registered by NEMAURA PHARMA LIMITED

NEMAURA PHARMA LIMITED has registered 3 patents

GB2482691 , GB2461355 , GB2467377 ,

Domain Names
We do not have the domain name information for NEMAURA PHARMA LIMITED
Trademarks

Trademark applications by NEMAURA PHARMA LIMITED

NEMAURA PHARMA LIMITED is the Original Applicant for the trademark NEMAURA ™ (WIPO1294203) through the WIPO on the 2015-12-24
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; pharmaceutical and medical compositions for human and/or veterinary use; diagnostic preparations and substances; medical diagnostic reagents; antiserums for diagnostic purposes; vaccines for human beings and/or animals; adjuvants for use with vaccines; biological laboratory preparations for medical and/or veterinary purposes; chemical preparations and reagents for medical, pharmaceutical and veterinary purposes; viruses for the treatment of humans and/or animals; diagnostic preparations for medical purposes; in-vitro diagnostics for medical purposes; in-vivo diagnostics for medical purposes; plasters; transdermal patches; transdermal plasters; transdermal therapeutic drug delivery systems (TTS) including patches/plasters treated or impregnated with pharmaceutical active ingredients; medicated transdermal drug delivery patches; vaccines; drug delivery agents; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations for injection; drug delivery agents in the form of liquid medications, tablets, powders, capsules, inhalants, nasal sprays, orally disintegrating tablets, mouthwashes, that facilitate the delivery of pharmaceutical preparations; balms for medical purposes; tonics for medical purposes; disinfectants, antiseptics.
Préparations pharmaceutiques et vétérinaires; préparations d'hygiène à usage médical; compositions pharmaceutiques et médicales à usage humain et/ou vétérinaire; substances et préparations de diagnostic; réactifs de diagnostic à usage médical; antisérums pour le diagnostic; vaccins pour êtres humains et/ou animaux; adjuvants à utiliser avec des vaccins; préparations biologiques de laboratoires à usage médical et/ou vétérinaire; préparations et réactifs chimiques à usage médical, pharmaceutique et vétérinaire; virus pour le traitement d'êtres humains et/ou animaux; préparations de diagnostic à usage médical; produits de diagnostic in vitro à usage médical; diagnostics in vivo à usage médical; emplâtres; timbres transdermiques; emplâtres transdermiques; systèmes thérapeutiques transdermiques pour l'administration de substances médicamenteuses (TTS), y compris timbres/emplâtres traités ou imprégnés avec des ingrédients actifs pharmaceutiques; timbres transdermiques médicamenteux pour l'administration de substances médicamenteuses; vaccins; agents de libération de médicaments; agents de libération de médicaments constitués de composés permettant la libération d'une grande variété de produits pharmaceutiques; préparations pharmaceutiques pour injections; agents pour l'administration de substances médicamenteuses sous forme de médicaments liquides, comprimés, poudres, gélules, produits à inhaler, sprays nasaux, comprimés orodispersibles, bains de bouche, facilitant l'administration de préparations pharmaceutiques; baumes à usage médical; reconstituants à usage médical; désinfectants, antiseptiques.
Preparaciones farmacéuticas y veterinarias; preparaciones sanitarias para uso médico; Composiciones farmacéuticas y medicinales para uso humano o veterinario; preparaciones y sustancias de diagnóstico; reactivos de diagnóstico médico; antisueros para fines de diagnóstico; vacunas para personas y/o animales; adyuvantes para vacunas; preparaciones biológicas de laboratorio para uso médico y/o veterinario; preparaciones y reactivos químicos para uso médico, farmacéutico y veterinario; virus para el tratamiento de seres humanos y/o animales; preparaciones de diagnóstico para uso médico; preparaciones para el diagnóstico in vitro de uso médico; diagnóstico in vivo para uso médico; emplastos; parches transdérmicos; emplastos transdérmicos; sistemas de administración transdérmica de medicamentos terapéuticos (TTS), incluidos parches/emplastos tratados o impregnados con ingredientes activos farmacéuticos; parches medicinales para la administración transdérmica de medicamentos; vacunas; agentes de liberación de medicamentos; agentes de administración de medicamentos que contienen compuestos que facilitan la administración de una amplia gama de productos farmacéuticos; productos farmacéuticos para inyecciones; agentes de administración de medicamentos en forma de medicamentos líquidos, tabletas, polvos, cápsulas, inhaladores, pulverizadores nasales, comprimidos por vía oral, enjuagues bucales, que facilitan la administración de preparaciones farmacéuticas; bálsamos para uso médico; reconstituyentes; Desinfectantes, antisépticos.
NEMAURA PHARMA LIMITED is the Original registrant for the trademark NANODERM ™ (77949040) through the USPTO on the 2010-03-03
Transdermal drug delivery patches featuring arrays of microneedles and sold with medication for use in the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain
NEMAURA PHARMA LIMITED is the Original registrant for the trademark BLACK ET BLANC ™ (85780422) through the USPTO on the 2012-11-15
Cosmetics, namely, skin conditions, skin moisturizers, body lotions, body emulsions, anti-aging creams, cuticle creams, face creams, hand creams, facial masks, skin peels, beauty serums, cloths or tissues impregnated with a skin cleanser, and make-up remover
Income
Government Income
We have not found government income sources for NEMAURA PHARMA LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72190 - Other research and experimental development on natural sciences and engineering) as NEMAURA PHARMA LIMITED are:

OAKLEA LTD. £ 237,880
TRL LIMITED £ 130,521
SGS MIS ENVIRONMENTAL LTD £ 18,077
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 13,354
WILDKNOWLEDGE LTD £ 8,604
FONTENERGY LTD £ 4,300
T-CUBED LTD £ 2,599
MARWELL WILDLIFE £ 1,089
CAMPDEN BRI (CHIPPING CAMPDEN) LIMITED £ 1,000
SITE ANALYTICAL SERVICES LIMITED £ 950
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
Outgoings
Business Rates/Property Tax
No properties were found where NEMAURA PHARMA LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by NEMAURA PHARMA LIMITED
OriginDestinationDateImport CodeImported Goods classification description
2015-07-0129371200Insulin and its salts, used primarily as hormones
2015-06-0129371200Insulin and its salts, used primarily as hormones
2015-06-0185369085Electrical apparatus for making connections to or in electrical circuits, for a voltage <= 1.000 V (excl. fuses, circuit breakers and other apparatus for protecting electrical circuits, relays and other switches, lamp holders, plugs and sockets, prefabricated elements for electrical circuits and other connections and contact elements for wire and cables and for wafer probers)
2015-01-0190183210Tubular metal needles, used in medical, surgical, dental or veterinary sciences
2013-02-0190019000Lenses, prisms, mirrors and other optical elements, of any material, unmounted (excl. such elements of glass not optically worked, contact lenses and spectacle lenses)
2011-12-0130044000
2011-10-0190268080Non-electronic instruments or apparatus for measuring or checking variables of liquids or gases, n.e.s.

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards
Technology Strategy Board Awards
NEMAURA PHARMA LIMITED has been awarded 4 awards from the Technology Strategy Board. The value of these awards is £ 556,762

CategoryAward Date Award/Grant
Micro Needle : Smart - Proof of Concept 2014-01-01 £ 100,000
Acne Prevention : Smart - Proof of Market 2013-12-01 £ 25,000
Nemaura Continuous Glucose Monitoring (CGM) Patch : Smart - Development of Prototype 2011-11-01 £ 250,000
Microsystems based self-regulating diagnostics : Collaborative Research and Development 2008-09-01 £ 181,762

How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.

European Union CORDIS Awards
The European Union has not awarded NEMAURA PHARMA LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.